CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells
暂无分享,去创建一个
Saijun Fan | G. Feng | Jia-li Dong | Lu Lu | Mian Jiang | Weili Liu | Ming Cui | Shu-qin Zhang | Jun Che | Hang Li
[1] Jing Lin,et al. Elevation of long non-coding RNA GAS5 and knockdown of microRNA-21 up-regulate RECK expression to enhance esophageal squamous cell carcinoma cell radio-sensitivity after radiotherapy. , 2019, Genomics.
[2] Zhuo Wang,et al. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective , 2019, Journal of Translational Medicine.
[3] H. Morgenstern,et al. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] K. Steele,et al. Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy , 2019, Journal of Immunotherapy for Cancer.
[5] Saijun Fan,et al. MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A. , 2019, Biochemical and biophysical research communications.
[6] F. Ciardiello,et al. Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC , 2019, Journal of Experimental & Clinical Cancer Research.
[7] Q. Song,et al. Radiotherapy for oligometastatic tumor improved the prognosis of patients with non‐small cell lung cancer (NSCLC) , 2019, Thoracic cancer.
[8] Jacquelyn O. Russell,et al. Hepatocyte‐Specific β‐catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate into Hepatocytes , 2019, The FASEB Journal.
[9] S. Bekiranov,et al. NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer , 2019, Cell Communication and Signaling.
[10] L. Amundadottir,et al. CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells , 2019, International journal of cancer.
[11] S. Forbes,et al. Hepatocyte‐Specific β‐Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes , 2019, Hepatology.
[12] Rolando Garcia-Milian,et al. Estrogen receptor-alpha isoforms are the main estrogen receptors expressed in non-small cell lung carcinoma , 2018, Steroids.
[13] Endi Wang,et al. X-ray irradiation induced Disabled-2 gene promoter de-methylation enhances radiosensitivity of non-small-cell lung carcinoma cells , 2018, Journal of experimental & clinical cancer research : CR.
[14] J. F. Burrows,et al. USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells , 2018, Cell Communication and Signaling.
[15] S. Yeh,et al. Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer , 2018, Oncogene.
[16] Xiao Wei,et al. 17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression , 2018, Journal of Experimental & Clinical Cancer Research.
[17] Wuwu Lv,et al. miR-495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells , 2018, Oncology reports.
[18] W. Bshara,et al. Smoking, Sex, and Non–Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424) , 2018, Journal of the National Cancer Institute.
[19] Hongbing Shen,et al. Fine mapping in TERT‐CLPTM1L region identified three independent lung cancer susceptibility signals: A large‐scale multi‐ethnic population study , 2018, Molecular carcinogenesis.
[20] Li Zhong,et al. rs401681 and rs402710 confer lung cancer susceptibility by regulating TERT expression instead of CLPTM1L in East Asian populations , 2018, Carcinogenesis.
[21] K. Luo,et al. The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling , 2018, Journal of Molecular Medicine.
[22] N. Liang,et al. Estrogen‐related receptor alpha triggers the proliferation and migration of human non‐small cell lung cancer via interleukin‐6 , 2018, Cell biochemistry and function.
[23] J. Dai,et al. A fast optimization approach for treatment planning of volumetric modulated arc therapy , 2018, Radiation Oncology.
[24] A. Chande,et al. Catalytic Enantioselective 1,3-Alkyl Shift in Alkyl Aryl Ethers: Efficient Synthesis of Optically Active 3,3'-Diaryloxindoles. , 2018, Angewandte Chemie.
[25] M. Young,et al. Timeless Is a Novel Estrogen Receptor Co-activator Involved in Multiple Signaling Pathways in MCF-7 Cells. , 2018, Journal of molecular biology.
[26] J. Willmann,et al. Intraoperative Resection Guidance with Photoacoustic and Fluorescence Molecular Imaging Using an Anti–B7-H3 Antibody-Indocyanine Green Dual Contrast Agent , 2018, Clinical Cancer Research.
[27] O. Brustugun,et al. Expression of Estrogen Receptor-α and Survival in Advanced-stage Non-small Cell Lung Cancer. , 2018, Anticancer research.
[28] J. Zhou,et al. Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway , 2018, Oncogene.
[29] B. Hui,et al. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells , 2018, Oncology reports.
[30] Xiaoting Zhang,et al. HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1. , 2018, Cancer research.
[31] N. M. Glykos,et al. Folding Simulations of a Nuclear Receptor Box-Containing Peptide Demonstrate the Structural Persistence of the LxxLL Motif Even in the Absence of Its Cognate Receptor. , 2018, The journal of physical chemistry. B.
[32] Jürgen Debus,et al. Oncogene addiction and radiation oncology: effect of radiotherapy with photons and carbon ions in ALK-EML4 translocated NSCLC , 2018, Radiation Oncology.
[33] Astrid Zimmermann,et al. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation , 2017, Radiation Oncology.
[34] J. Gustafsson,et al. ERβ Sensitizes NSCLC to Chemotherapy by Regulating DNA Damage Response , 2017, Molecular Cancer Research.
[35] V. Brower. Adding radiotherapy to chemotherapy in advanced NSCLC. , 2017, The Lancet. Oncology.
[36] Jae-Ho Lee,et al. A TERT-CLPTM1 locus polymorphism (rs401681) is associated with EGFR mutation in non-small cell lung cancer. , 2017, Pathology, research and practice.
[37] Harini Krishnan,et al. Estrogen Receptor α- and β-Interacting Proteins Contain Consensus Secondary Structures: An Insilico Study , 2017, Annals of Neurosciences.
[38] Hyoung-Tae Kim,et al. Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis. , 2017, Cell reports.
[39] L. Milanesi,et al. The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading , 2017, Genome Biology.
[40] Jason Gertz,et al. Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer , 2017, bioRxiv.
[41] Y. Miller,et al. Clinical Utility of Chromosomal Aneusomy in Individuals at High Risk of Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[42] W. Chiu,et al. Structural and Functional Impacts of ER Coactivator Sequential Recruitment. , 2017, Molecular cell.
[43] Lin Chen,et al. Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity. , 2017, Gene.
[44] Hongbing Shen,et al. Fine mapping of chromosome 5p15.33 identifies novel lung cancer susceptibility loci in Han Chinese , 2017, International journal of cancer.
[45] Q. Fu,et al. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma , 2017, Clinical Cancer Research.
[46] Conor K McGarry,et al. Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[47] T. Efstathiou,et al. Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cells , 2017, Cell Communication and Signaling.
[48] Carl-Magnus Clausson,et al. Insufficient antibody validation challenges oestrogen receptor beta research , 2017, Nature Communications.
[49] Zhi-rui Zhou,et al. Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[50] H. Ditzel,et al. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC , 2017, Journal of the National Cancer Institute.
[51] D. Cox,et al. A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus , 2017, npj Genomic Medicine.
[52] J. Hartman,et al. Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells , 2017, Journal of the National Cancer Institute.
[53] O. Kallioniemi,et al. Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1. , 2017, Cell reports.
[54] Xiang Wang,et al. miR-21-mediated Radioresistance Occurs via Promoting Repair of DNA Double Strand Breaks* , 2017, The Journal of Biological Chemistry.
[55] P. Wei,et al. Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2 , 2016, Cell Research.
[56] Tangchun Wu,et al. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer , 2016, Cancer Gene Therapy.
[57] Shin Jung,et al. Enhancement of radiosensitivity by inhibition of c-Jun N-terminal kinase activity in a Lewis lung carcinoma‑bearing subcutaneous tumor mouse model. , 2016, Oncology reports.
[58] E. Richardsen,et al. Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer , 2016, Steroids.
[59] N. Yu,et al. Roles of ERα and ERβ in estrogen-induced DDP chemoresistance in non-small cell lung cancer. , 2016, Genetics and molecular research : GMR.
[60] Hyun-Jin Kang,et al. Correction to “The Dynamic Character of the BCL2 Promoter i-Motif Provides a Mechanism for Modulation of Gene Expression by Compounds That Bind Selectively to the Alternative DNA Hairpin Structure” , 2016, Journal of the American Chemical Society.
[61] Geoffrey Liu,et al. Systematic Review of Genetic Variation in Chromosome 5p15.33 and Telomere Length as Predictive and Prognostic Biomarkers for Lung Cancer , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[62] Z. Du,et al. Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma , 2016, Scientific Reports.
[63] Qingqing Zhu,et al. Prognostic value of the expression of estrogen receptor β in patients with non-small cell lung cancer: a meta-analysis. , 2016, Translational lung cancer research.
[64] Y. Matsumoto,et al. LIG4 mediates Wnt signalling-induced radioresistance , 2016, Nature Communications.
[65] S. Jun,et al. Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer , 2016, Scientific Reports.
[66] L. Kang,et al. CLPTM1L polymorphism as a protective factor for lung cancer: a case–control study in southern Chinese population , 2016, Tumor Biology.
[67] Xuming Luo,et al. Prognostic significance of CLPTM1L expression and its effects on migration and invasion of human lung cancer cells. , 2016, Cancer biomarkers : section A of Disease markers.
[68] L. Tse,et al. Prognostic value of estrogen receptors mRNA expression in non-small cell lung cancer: A systematic review and meta-analysis , 2015, Steroids.
[69] Z. Cai,et al. Rs401681 polymorphism in TERT-CLPTM1L was associated with bladder cancer risk: A meta-analysis , 2015, Iranian journal of basic medical sciences.
[70] K. Dahlman-Wright,et al. Estrogen receptor alpha and beta in health and disease. , 2015, Best practice & research. Clinical endocrinology & metabolism.
[71] Shuhang Wang,et al. ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations , 2015, Scientific Reports.
[72] K. Horie-Inoue,et al. Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology , 2014, Acta Pharmacologica Sinica.
[73] Hong Wang,et al. CLPTM1L Genetic Polymorphisms and Interaction With Smoking and Alcohol Drinking in Lung Cancer Risk , 2014, Medicine.
[74] K. Ang,et al. miR-205 acts as a tumor radiosensitizer by targeting ZEB1 and Ubc13 , 2014, Nature Communications.
[75] Sheng Zhou,et al. Fulvestrant-Mediated Inhibition of Estrogen Receptor Signaling Slows Lung Cancer Progression , 2014, Oncology research.
[76] W. Lim,et al. Serum estrogen receptor beta mediated bioactivity correlates with poor outcome in lung cancer patients. , 2014, Lung cancer.
[77] William Wheeler,et al. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. , 2014, Human molecular genetics.
[78] M. Tsao,et al. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC). , 2014, Lung cancer.
[79] Baosen Zhou,et al. Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer: a case–control study in northeast Chinese male population , 2014, Medical Oncology.
[80] S. Thorgeirsson,et al. CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. , 2014, Cancer research.
[81] Hyun-Jin Kang,et al. The Dynamic Character of the BCL2 Promoter i-Motif Provides a Mechanism for Modulation of Gene Expression by Compounds That Bind Selectively to the Alternative DNA Hairpin Structure , 2014, Journal of the American Chemical Society.
[82] M. You,et al. Crr9/clptm1l Regulates Cell Survival Signaling and Is Required for Ras Transformation and Lung Tumorigenesis Figures: 7 Main Text and 7 Supplementary , 2022 .
[83] Baosen Zhou,et al. Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[84] F. Sarkar,et al. DIM (3,3′-diindolylmethane) confers protection against ionizing radiation by a unique mechanism , 2013, Proceedings of the National Academy of Sciences.
[85] Sandra A O'Toole,et al. Molecular biology of lung cancer. , 2013, Journal of thoracic disease.
[86] Yong-Jun Zhang,et al. No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[87] Yu Zhao,et al. The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells , 2013, International journal of cancer.
[88] Peter Kraft,et al. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression , 2013, Human molecular genetics.
[89] Chawnshang Chang,et al. Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2 , 2012, Oncology reports.
[90] Zonghai Li,et al. The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines. , 2012, Lung cancer.
[91] H. Nguyen,et al. Estrogen receptor α/β-cofactor motif interactions; interplay of tyrosine 537/488 phosphorylation and LXXLL motifs. , 2012, Molecular bioSystems.
[92] Hongbing Shen,et al. Common genetic variants in TERT contribute to risk of cervical cancer in a Chinese population , 2012, Molecular carcinogenesis.
[93] Sichun Yang,et al. Identification of a Novel LXXLL Motif in α-Actinin 4-spliced Isoform That Is Critical for Its Interaction with Estrogen Receptor α and Co-activators* , 2012, The Journal of Biological Chemistry.
[94] J. Xiang,et al. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy , 2012, Cancer Gene Therapy.
[95] H. Sasano,et al. Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma , 2012, Expert opinion on therapeutic targets.
[96] A. Cheng,et al. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma , 2012, Acta Neuropathologica.
[97] Jane E. Carpenter,et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer , 2011, Nature Genetics.
[98] K. Lu,et al. Estrogen receptor β signaling regulates the progression of Chinese non-small cell lung cancer , 2011, The Journal of Steroid Biochemistry and Molecular Biology.
[99] Z. Szallasi,et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.
[100] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[101] J. Seo,et al. Retinoic Acid as a Radiosensitizer on the Head and Neck Squamous Cell Carcinoma Cell Lines. , 2001, Cancer research and treatment : official journal of Korean Cancer Association.
[102] A. Okamoto,et al. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. , 2001, Biochemical and biophysical research communications.
[103] G. Stancel,et al. Identification of an estrogen response element in the 3'-flanking region of the murine c-fos protooncogene. , 1992, The Journal of biological chemistry.